SCHEMBL6037880

SCHEMBL6037880

C[N]c1ccccc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.58
HSD17B10 Q99714 1/20 0.54
TDP1 Q9NUW8 4/20 0.50
ALDH1A1 P00352 4/20 0.48
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIN3A Q8TCU5 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
TSHR P16473 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 1/20 0.45
GPR35 Q9HC97 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3184824 0.82 PLAU (0.62) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL4365348 0.80 PLAU (0.60) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL30184963 0.80 PLAU (0.60) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL10768606 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL30184964 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL8013238 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL10798681 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL28331734 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL16665353 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D
SCHEMBL2374739 0.78 PLAU (0.58) PLAUHSD17B10TDP1ALDH1A1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4269773-A CEPHALOSPORINS SHIONOGI & CO., LTD. (JP) 1981-05-26 US claimed
US-20060252051-A1 Method for producing diverse libraries of encoded polymers JOHN HOPKINS UNIVERSITY, THE 2006-11-09 US disclosed
WO-2004087730-A2 METHOD FOR PRODUCING DIVERSE LIBRARIES OF ENCODED POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2004-10-14 WO disclosed
US-4269773-A CEPHALOSPORINS SHIONOGI & CO., LTD. (JP) 1981-05-26 US disclosed
US-4159984-A METAL AND PROTON DONOR SHIONOGI & CO., LTD. (JP) 1979-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252051-A1 Method for producing diverse libraries of encoded polymers NSUN3, TRMT1, TARBP1 PLAU 1743/4885HSD17B10 2185/4885TDP1 838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.